Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis
Seyran Naghdi, Martin Underwood, Jason Madan, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Multiple Binding Modes of Inhibitors to Human Carbonic Anhydrases: An Update on the Design of Isoform-Specific Modulators of Activity
Katia D’Ambrosio, Anna Di Fiore, Vincenzo Alterio, et al.
Chemical Reviews (2024)
Closed Access | Times Cited: 6
Combining treatments for migraine prophylaxis: the state-of-the-art
Lanfranco Pellesi, David García‐Azorín, Eloísa Rubio‐Beltrán, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Health-related quality of life among women and men living with migraine: a Canada-wide cross-sectional study
Alexander C. T. Tam, Hiten Naik, Logan Trenaman, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Understanding the efficacy and tolerability of migraine treatment: a deep dive into CGRP antagonists
Marta Waliszewska‐Prosół, Bianca Raffaelli, Marcin Straburzyński, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 11, pp. 1039-1051
Closed Access | Times Cited: 4
Chronic Migraine in Adults
Rebecca Burch
JAMA (2025)
Closed Access
Research priorities for randomised controlled trials in chronic migraine preventive medication: A stakeholder consensus workshop
Sophie Rees, Andrew Cooklin, Callum Duncan, et al.
NIHR Open Research (2025) Vol. 4, pp. 16-16
Open Access
Competing treatments for migraine: a headache for decision-makers
Hema Mistry, Seyran Naghdi, Martin Underwood, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
Dilara Onan, Fatemeh Farham, Paolo Martelletti
Toxins (2024) Vol. 16, Iss. 7, pp. 309-309
Open Access | Times Cited: 3
Subarachnoid Hemorrhage Depletes Calcitonin Gene-Related Peptide Levels of Trigeminal Neurons in Rat Dura Mater
Thannoon Masood, Szandra Lakatos, Gyöngyi Kis, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 653-653
Open Access | Times Cited: 2
Multimodal digital health treatments for Chronic Migraine associated with Medication Overuse Headache: a literature appraisal and results of a single-arm open trial (the BE-HOME program)
Licia Grazzi, Danilo Antonio Montisano, Domenico D’Amico, et al.
Neurological Sciences (2024) Vol. 45, Iss. 10, pp. 4923-4930
Closed Access | Times Cited: 2
Does pain self-efficacy predict, moderate or mediate outcomes in people with chronic headache; an exploratory analysis of the CHESS trial
Siew Wan Hee, Shilpa Patel, Harbinder Sandhu, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Research priorities for randomised controlled trials in chronic migraine preventive medication: A stakeholder consensus workshop
Sophie Rees, Andrew Cooklin, Callum Duncan, et al.
NIHR Open Research (2024) Vol. 4, pp. 16-16
Open Access
Efficacy and Tolerability of Erenumab and Topiramate for Prevention of Chronic Migraine: A Retrospective Cohort Study
Eslam El Nebrisi, Zainaba Suaad Ahmed Ruwayya, Dalya Ibrahim Alzayori, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1684-1684
Open Access
Migraine treatment: Position paper of the French Headache Society
Xavier Moisset, Geneviève Demarquay, Solène de Gaalon, et al.
Revue Neurologique (2024)
Open Access
The Association Between Body Fat Percentage and Severe Headache or Migraine: A National Cross-Sectional Survey
Rongjiang Xu, Liang Dong, Xiaonuo Xu, et al.
Cureus (2024)
Open Access
Scoping Review: The Effects of Interrupted Onabotulinumtoxin A Treatment for Chronic Migraine Prevention During the COVID-19 Pandemic
Qing Ruan, Daniel Pak, Amitabh Gulati, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 4163-4176
Open Access
Does pain self-efficacy predict outcomes in people with migraine; an exploratory analysis of the CHESS trial
Siew Wan Hee, Shilpa Patel, Harbinder Sandhu, et al.
Research Square (Research Square) (2024)
Open Access
Hilfestellungen zur wirtschaftlichen Verordnung monoklonaler Antikörper
Jörg Hohmann
NeuroTransmitter (2024) Vol. 35, Iss. 4, pp. 34-37
Closed Access
Peer Review Report For: Research priorities for randomised controlled trials in chronic migraine preventive medication: A stakeholder consensus workshop [version 1; peer review: 2 approved with reservations]
Raquel Gil‐Gouveia
(2024)
Open Access
Enhancing the Understanding of Anti-calcitonin Gene-related Peptide Monoclonal Antibodies in Chronic Migraine Prevention
Prashant Soni
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 4, pp. 697-698
Open Access
Comparative Effectiveness of Pharmacological versus Non-pharmacological Interventions for Migraine Management: A Meta-analysis
Ali Abed Alsakhairi, Laura Almazyad, Abdullah Alarifi, et al.
(2024) Vol. 1, Iss. 3, pp. 876-884
Closed Access
Page 1

Scroll to top